focus -WSS

focus

author：Wikipedia 2025-09-27 12:48:03 - browse：6

Doctor sitting at a crowded desk. -- first opinion coverage from STAT — Adobe

SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

“It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Average age of first period drops to 11.9 years, study shows

focus

WSS

Alabama IVF ruling threatens families facing fatal genetic disease

Stigma and the return of syphilis

Community Health Systems hospitals under DOJ investigation

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Akili, maker of video game for ADHD, to be acquired for 34 million

6 phony surgeries that take placebo to the extreme

focus

focus

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AI used to predict Covid

Drug repurposing or repositioning? The language matters

6 phony surgeries that take placebo to the extreme

How to save PrEP access — and even expand it

New documents shed light on MD Anderson Cancer Institute feud

Psychedelics group wrestles with new pharma identity

Health insurers say they are turning to AI to cut costs, improve care

Peter Hotez and the public health issue of online harassment

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

hotspot

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Why palliative psychiatry is worth discussing

Average age of first period drops to 11.9 years, study shows

Medicare inequities exacerbate Puerto Rico’s health disparities

New documents shed light on MD Anderson Cancer Institute feud

Average age of first period drops to 11.9 years, study shows

knowledge

entertainment

focus

explore